Clinical Images: A Rare Case of Cryptococcal Meningoencephalitis in an Immunocompetent Patient

REFERENCES

1. ↵
   1. Kaplan JE.,
   2. Hanson D.,
   3. Dworkin MS.,
   4. et al.

   Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000 4; 30 Suppl 1: S5- S14. pmid:10770911

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. MacDougall L.,
   2. Kidd SE.,
   3. Galanis E.,
   4. et al.

   Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis. 2007 1; 13 1: 42- 50. doi: 10.3201/eid1301.060827. pmid:17370514

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Park BJ.,
   2. Wannemuehler KA.,
   3. Marston BJ.,
   4. Govender N.,
   5. Pappas PG.,
   6. Chiller TM.

   Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009 2 20; 23 4: 525- 530. doi: 10.1097/QAD.0b013e328322ffac. pmid:19182676

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Bratton EW.,
   2. El Husseini N.,
   3. Chastain CA.,
   4. et al.

   Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One. 2012; 7(8):e43582. doi: 10.1371/journal.pone.0043582. Erratum in: PLoS One. 2012; 7 10 doi: 10.1371/annotation/a94bc542-6682-4579-a315-57019cef7e0e.
5. ↵
   1. Brizendine KD.,
   2. Baddley JW.,
   3. Pappas PG.

   Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status. PLoS One. 2013; 8 3: e60431 doi: 10.1371/journal.pone.0060431. pmid:23555970

   OpenUrlCrossRefPubMed
6. ↵
   1. Charlier C.,
   2. Dromer F.,
   3. Lévêque C.,
   4. et al.

   French Cryptococcosis Study Group. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One. 2008 4 16; 3 4: e1950 doi: 10.1371/journal.pone.0001950. pmid:18414656

   OpenUrlCrossRefPubMed
7. ↵
   1. Tunkel AR.,
   2. Hartman BJ.,
   3. Kaplan SL.,
   4. et al.

   Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 11 1; 39 9: 1267- 1284. pmid:15494903

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Perfect JR.,
   2. Dismukes WE.,
   3. Dromer F.,
   4. et al.

   Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010 2 1; 50 3: 291- 322. doi: 10.1086/649858. pmid:20047480

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Pappas PG.,
   2. Bustamante B.,
   3. Ticona E.,
   4. et al.

   Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis. 2004 6 15; 189 12: 2185- 2191. pmid:15181565

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Panackal AA.,
    2. Komori M.,
    3. Kosa P.,
    4. et al.

    Spinal arachnoiditis as a complication of cryptococcal meningoencephalitis in non-HIV previously healthy adults. Clin Infect Dis. 2017 2 1; 64 3: 275- 283. doi: 10.1093/cid/ciw739. pmid:28011613

    OpenUrlCrossRefPubMed
11. ↵
    Appropriateness Criteria. American College of Radiology. https://acsearch.acr.org/list. Accessed February 10, 2017.